BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 31, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2017
View Archived Issues
Halozyme Therapeutics begins trial of PEGPH20 plus atezolizumab
Read More
NIH grant supports Crinetics' development of CRN-00808 for acromegaly
Read More
Roche and Genentech patent JAK inhibitors
Read More
Bayer discloses TBK1 and IKK-E inhibitors
Read More
Sichuan Haisco Pharmaceutical divulges CACNA2D1 ligands
Read More
EMBL and Savira Pharmaceuticals discover compounds for treating influenza
Read More
GlaxoSmithKline patents RIP-1 inhibitors
Read More
Amgen files to add OS data from ENDEAVOR to Kyprolis label in U.S. and E.U.
Read More
VSIG4 g.18115T allele tied to rheumatoid arthritis severity in females
Read More
Prima BioMed to receive second milestone payment from IMP-701 collaboration with Novartis
Read More
New phase I trial evaluates MK-1308 with pembrolizumab in advanced solid tumors
Read More
Emergent BioSolutions agrees to acquire Sanofi's ACAM2000 business
Read More
FDA grants orphan drug designation to NanoCarrier's epirubicin-conjugated polymer micelles
Read More
IL-13RA2 found as a therapeutic target for treating IBD
Read More
FDA issues complete response letter for Evenity for postmenopausal osteoporosis
Read More
FDA awards orphan drug designation to liposomal vinorelbine for soft tissue carcinoma
Read More
WOL-074-029, a novel KdPT analogue, shows anti-inflammatory properties with topical application
Read More
Merck & Co. divulges HIV integrase inhibitors
Read More
EMA committee recommends approval of label update for Lixiana
Read More
Enterin completes series A financing to help advance trial of ENT-01
Read More
Asterias completes dosing in AIS-A 20 million cell cohort in SCiStar study of AST-OPC1
Read More
Dosing begins in phase Ib/II trial of APX-005M with Opdivo in advanced solid tumors
Read More
Ionis earns milestone under neurological collaboration with Biogen
Read More
